A detailed history of Clarity Capital Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Clarity Capital Partners LLC holds 308 shares of LLY stock, worth $273,180. This represents 0.17% of its overall portfolio holdings.

Number of Shares
308
Previous 389 20.82%
Holding current value
$273,180
Previous $303 Million 7.85%
% of portfolio
0.17%
Previous 0.2%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$724.87 - $909.04 $58,714 - $73,632
-81 Reduced 20.82%
308 $279 Million
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $230,365 - $308,196
389 New
389 $303 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Clarity Capital Partners LLC Portfolio

Follow Clarity Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarity Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarity Capital Partners LLC with notifications on news.